Stock Events

Stock Events

Recordati SpA 

$15.67
176
+$0.43+2.8% Thursday 15:56

Statistics

Day High
13.21
Day Low
13.21
52W High
17.16
52W Low
9.29
Volume
146
Avg. Volume
1,538
Mkt Cap
3.28B
P/E Ratio
20.99
Dividend Yield
2.48%
Dividend
0.39

Upcoming

Dividends

2.48%Dividend Yield
Jun 26
$0.21
Dec 25
$0.18
Jun 25
$0.19
Dec 24
$0.16
Jun 24
$0.17
10Y Growth
N/A
5Y Growth
N/A
3Y Growth
N/A
1Y Growth
11.83%

Earnings

10NovExpected
Q1 2025
Q2 2025
Q3 2025
Q4 2025
Q1 2026
Q2 2026
Next
0.58
0.65
0.73
0.8
Expected EPS
N/A
Actual EPS
N/A

Financials

16.91%Profit Margin
Profitable
2020
2021
2022
2023
2024
2025
3.01BRevenue
509.62MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow RICFY. It's not an investment recommendation.
Enel Spa
30
ENEL.MI
Intesa Sanpaolo Spa
23
ISP.MI
Eni Spa
23
ENI.MI
Poste Italiane S.p.a
23
PST.MI

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Novartis
NVS
Mkt Cap286.78B
Novartis is a global healthcare company that competes with Recordati in the pharmaceuticals sector, particularly in the development and marketing of prescription medications.
Pfizer
PFE
Mkt Cap152.69B
Pfizer is a large pharmaceutical company that competes directly with Recordati in the development and distribution of drugs across various therapeutic areas.
Merck
MRK
Mkt Cap335.14B
Merck & Co. is a leading pharmaceutical company that competes with Recordati in the research, development, and marketing of drugs, especially in the areas of cardiovascular diseases.
Abbvie
ABBV
Mkt Cap440.83B
AbbVie competes with Recordati in the pharmaceutical industry, particularly in the development of therapies for diseases in areas like immunology and oncology, which may overlap with Recordati's product offerings.
GSK
GSK
Mkt Cap99.18B
GlaxoSmithKline is a global healthcare company that competes with Recordati in the pharmaceutical and healthcare sector, including the development of medications for various diseases.
Astrazeneca
AZN
Mkt Cap242.64B
AstraZeneca is a multinational pharmaceutical and biopharmaceutical company that competes with Recordati in the development and marketing of prescription medicines, particularly in the cardiovascular, renal, and metabolism therapeutic areas.
Sanofi
SNY
Mkt Cap104.76B
Sanofi is a global healthcare leader that competes with Recordati in the pharmaceutical sector, offering a wide range of prescription medicines, vaccines, and over-the-counter healthcare products.
Bristol-Myers Squibb
BMY
Mkt Cap130.39B
Bristol Myers Squibb is a global biopharmaceutical company that competes with Recordati in the discovery, development, and delivery of medicines in areas such as cardiovascular, oncology, and immunoscience.
Johnson & Johnson
JNJ
Mkt Cap627.42B
Johnson & Johnson is a diversified healthcare giant that competes with Recordati not only in the pharmaceutical sector but also in consumer health products and medical devices.
Teva- Pharmaceutical Industries
TEVA
Mkt Cap42.85B
Teva Pharmaceutical Industries is a global leader in generic and specialty medicines, competing with Recordati in the generic drug market and in the development of specialty pharmaceuticals.

About

RECORDATI INDUSTRIA CHIM
Show more...
CEO
Robert Koremans
Employees
4693
Country
Italy
ISIN
US75625L1008

Listings

MX
MX
RECN.MX
STU
DE
RER1.STU
LSE
GB
0KBS.LSE
VI
AT
REC.VI

0 Comments

Share your thoughts

FAQ

What is Recordati SpA stock price today?▼
The current price of RICFY is $15.67 USD — it has increased by +2.8% in the past 24 hours. Watch Recordati SpA stock price performance more closely on the chart.
What is Recordati SpA stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on OTC Link exchange Recordati SpA stocks are traded under the ticker RICFY.
Is Recordati SpA stock price growing?▼
RICFY stock has risen by +18.64% compared to the previous week, the month change is a +5.61% rise, over the last year Recordati SpA has showed a +3.78% increase.
What is Recordati SpA market cap?▼
Today Recordati SpA has the market capitalization of 3.28B
When is the next Recordati SpA earnings date?▼
Recordati SpA is going to release the next earnings report on November 10, 2026.
What is Recordati SpA revenue for the last year?▼
Recordati SpA revenue for the last year amounts to 3.01B USD.
What is Recordati SpA net income for the last year?▼
RICFY net income for the last year is 509.62M USD.
Does Recordati SpA pay dividends?▼
Yes, RICFY dividends are paid semi-annual. The last dividend per share was 0.21 USD. As of today, Dividend Yield (FWD)% is 2.48%.
How many employees does Recordati SpA have?▼
As of August 21, 2026, the company has 4,693 employees.
In which sector is Recordati SpA located?▼
Recordati SpA operates in the Health & Wellness sector.
When did Recordati SpA complete a stock split?▼
The last stock split for Recordati SpA was on April 18, 2005 with a ratio of 4:1.
Where is Recordati SpA headquartered?▼
Recordati SpA is headquartered in Milan, Italy.